Metrics Operations Pharmaceuticals 
Harvard Business
MARCH 21, 2018
These kinds of statements speak to a leader’s choice of values, and a failure to understand the relationships between a safe work environment and operational performance. The reality is that virtually all workplace injuries are preventable, and safety management and operational excellence are intimately linked. At Cummins, Inc.,
Harvard Business
NOVEMBER 29, 2018
A core challenge of management is to ensure that the organization’s priorities, strategies, and metrics are consistently embraced and that any impediments are identified and addressed quickly. Metrics that are reported daily, such as “units at capacity.” CAPTION TEXT HERE/Getty Images.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business
OCTOBER 25, 2018
To analyze the superstar dynamics of firms, our metric was economic profit, a measure of a firm’s profit above and beyond opportunity cost. (To The top 10% of the firms we analyzed — the superstars by our metric — create 80% of all the economic value, meaning they account for 80% of economic profits.
Harvard Business
JUNE 22, 2016
For example, do you make and sell things, hire skilled employees and provide services, develop and new IP like software or pharmaceuticals, or build and manage digital networks, be they transactional, informational, or social? This will require reporting on new metrics. Finally, begin to track the progress of your network initiative.
Harvard Business
OCTOBER 6, 2016
We mapped this data against dozens of financial and leadership metrics, clustering companies into four groups (ranging from low- to high-performing). And fifth, while these companies do have leadership “programs,” they are embedded in the business, and HR does not operate alone.
Harvard Business
NOVEMBER 1, 2017
One of the key metrics that the Omada program tracks is participants’ weight. While the in-person DPPs were largely successful in reducing disease risk and incidence, Duffy and James recognized that there was substantial opportunity to better scale the DPP and make it more accessible and personalized by using technology.
Harvard Business
JUNE 23, 2016
A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. While a natural inclination, this group is (by design) representative of current operating units and functions, which often have a status quo to defend. paul Garbett for HBR.
Expert insights. Personalized for you.
189 
Let's personalize your content